Updated Date:
28 Oct 2025
Product Detail:
APIDRA insulin glulisine (rbe) 100IU/mL 10 mL injection vial
Shortage Status:
Discontinued
AUST R:
99145
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
Insulin glulisine
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,solution
Supply Impact Dates
Management Action:
Alternative presentations are available.
